Analyst Ratings for Core Laboratories N.V. (CLB)

Updated: 2017-07-28

Analysts covering Core Laboratories N.V. (NYSE:CLB) have given it a consensus rating of Overweight. About 30 days ago, CLB was issued an average rating of Overweight.

19 analysts issued ratings on the stock, where 7 gave CLB a buy rating, 1 gave an overweight rating, 11 gave a hold rating, 0 issued an underweight rating, and 0 gave a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has decreased by 1.

Investment analysts gave a few price targets for CLB. The most optimistic analyst gave a price target of 140, implying potential capital gains of 37.92 percent. The minimum price target given was 100, which equates to a potential downside of -1.49 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.

Analysts have revised their earnings estimates downwards for this quarter, by about -2.5 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -1.71 percent. On the other hand, earnings estimates for the fiscal year have been revised downwards by -0.7 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of 0.01 percent in FY estimates.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 0 analysts increased their quarterly estimates, while 2 analysts revised their estimates downwards. Over the same time period, 0 analysts revised their FY earnings estimates upwards, compared to 3 analysts that revised their FY estimates downwards.

The growth rate of CLB's earnings is estimated by analysts to be 32.7 percent. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. A lower PEG ratio is favorable, because that is often interpreted as the company being fairly priced relative to its growth rate. People often look for the PEG ratio to be under 1, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of CLB is 1.9.

CLB has traded between a high of 125.83 and a low of 96.30 over the past year. The current market price is above the trailing year's low by 5.41 percent, and 19.33 percent lower than its 52-week high. CLB has a P/E ratio of 62.01. Investors typically compare the P/E ratio to a company's peers in the industry. The CLB value stock report compares CLB to some of its peers using value stock charts. The market cap of CLB is $4.34 billion. CLB's next earnings release will be on 0000-00-00, which is days away.